Dr Martinelli speaks with ecancertv at ASH 2016 to give his highlights from the conference.

Overall, he describes research presented at this years conference as among the most invigorating in haemato-oncology after many years of incremental gains.

For more on venetoclax, ecancer spoke with Dr Andrew Wei here.

ecancer covered updates of blinatumomab for paediatric ALL here.

For more on CPX351, watch Prof Jeffery Lancet present the results in a press conference here.

For more updates, watch the roundtable discussion on advances in CLL.

For all of our coverage from the conference, click here.

ecancer's filming at ASH 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.